InsidersTradesSigma
Alzinova AB: directors' dealings · Finland · FIN-FSA
FI:alzinova-abSE0007413455FI·FIN-FSAMcap 68M€Healthcare
Explore the full insider trade history of Alzinova AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Alzinova AB has recorded 17 insider filings. Market capitalisation: €68.1m. The latest transaction was filed on 26 May 2026 (Purchase). Among the most active insiders: Erik Kullgren. All data is free.
17
Insider Decl.
0
Thresholds
€59,163
17 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.44 €
Analyst consensus
2 analystsStrong buy
2.00 €Target 2.30 €(+423%)2.60 €
Income statement
Gross profit26.6 M€
Net income−26.3 M€-103.6% margin
Valuation
PER (forward)-0.9x
P/Book0.4x
Balance sheet & cash
Market cap68.1 M€
Total debt800 k€
Free Cash Flow−39.6 M€
Debt / Equity1%
Profitability & ownership
ROE-19.9%
ROA-10.8%
% insiders17.8%
% institutions8.6%
Last declaration on 26 May 2026
Declarations17 total
Executives●Purchase30FIN-FSA
€52850,000 shares@ €0.01060.0008% mcap2.2% of flow
Teckningsoption
FI:A003Z174-1·
Ideal exit: 20 Feb 2027 (T+270)
Executives●Purchase0FIN-FSA
€85520,000 shares@ €0.0428
Aktie
FI:A003Z110-1·
Ideal exit: 19 Feb 2027 (T+270)
Executives●Purchase0FIN-FSA
€98623,057 shares@ €0.0428
Aktie
FI:A003Z108-1·
Ideal exit: 19 Feb 2027 (T+270)
Executives●Purchase31FIN-FSA
€2,28550,000 shares@ €0.04570.0034% mcap9.6% of flow
Aktie
FI:A003Z007-1·
Ideal exit: 15 Feb 2027 (T+270)
Executives●Purchase24FIN-FSA
€2,19440,000 shares@ €0.05480.0032% mcap10.2% of flow
Aktie
FI:A003X505-1·
Ideal exit: 27 Dec 2026 (T+270)
Executives●Purchase27FIN-FSA
€1,84010,000 shares@ €0.1840.0027% mcap8.5% of flow
BTA (betald tecknad aktie)
FI:A003O011-1·
Ideal exit: 31 Jan 2026 (T+270)
Executives●Purchase23FIN-FSA
€9104,943 shares@ €0.1840.0013% mcap100.0% of flow
BTA (betald tecknad aktie)
FI:A003O010-1·
Ideal exit: 31 Jan 2026 (T+270)
Executives●Purchase21FIN-FSA
€12,015500,000 shares@ €0.0240.018% mcap100.0% of flow
Teckningsoption
FI:A003N293-1·
Ideal exit: 29 Dec 2025 (T+270)
Executives●Purchase24FIN-FSA
€6,007250,000 shares@ €0.0240.0088% mcap100.0% of flow
Teckningsoption
FI:A003N240-1·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase18FIN-FSA
€6393,700 shares@ €0.17280.0009% mcap25.1% of flow
Aktie
FI:A003N212-1·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase24FIN-FSA
€6,007250,000 shares@ €0.0240.0088% mcap100.0% of flow
Teckningsoption
FI:A003N211-1·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase24FIN-FSA
€1,72610,000 shares@ €0.17260.0025% mcap8.0% of flow
Aktie
FI:A003N210-1·
Ideal exit: 30 Dec 2025 (T+270)
Executives●Purchase31FIN-FSA
€12,015500,000 shares@ €0.0240.018% mcap55.7% of flow
Teckningsoption
FI:A003N209-1·
Ideal exit: 29 Dec 2025 (T+270)
Executives●Purchase33FIN-FSA
€3,71920,000 shares@ €0.18590.0055% mcap68.2% of flow
Aktie
FI:A003N189-1·
Ideal exit: 28 Dec 2025 (T+270)
Executives●Purchase29FIN-FSA
€1,73810,000 shares@ €0.17380.0026% mcap31.8% of flow
Aktie
FI:A003N190-1·
Ideal exit: 29 Dec 2025 (T+270)
Executives●Purchase18FIN-FSA
€1,90610,000 shares@ €0.19060.0028% mcap74.9% of flow
Aktie
FI:A003N143-1·
Ideal exit: 28 Dec 2025 (T+270)
Executives●Purchase25FIN-FSA
€3,79320,000 shares@ €0.18970.0056% mcap17.6% of flow
Aktie
FI:A003N138-1·
Ideal exit: 28 Dec 2025 (T+270)
17 of 17 declarations